Daiwa Securities Group Inc. Has $877,000 Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Daiwa Securities Group Inc. raised its position in Henry Schein, Inc. (NASDAQ:HSIC) by 6.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 11,590 shares of the company’s stock after acquiring an additional 717 shares during the period. Daiwa Securities Group Inc.’s holdings in Henry Schein were worth $877,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Xponance Inc. lifted its holdings in Henry Schein by 2.1% during the third quarter. Xponance Inc. now owns 21,839 shares of the company’s stock worth $1,622,000 after acquiring an additional 443 shares during the period. Everett Harris & Co. CA lifted its holdings in Henry Schein by 29.1% during the fourth quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock worth $7,925,000 after acquiring an additional 23,622 shares during the period. Sprucegrove Investment Management Ltd. lifted its holdings in Henry Schein by 14.2% during the fourth quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company’s stock worth $16,693,000 after acquiring an additional 27,500 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Henry Schein by 215.6% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 74,251 shares of the company’s stock worth $5,622,000 after acquiring an additional 50,723 shares during the period. Finally, Caxton Associates LP lifted its holdings in Henry Schein by 80.8% during the third quarter. Caxton Associates LP now owns 18,991 shares of the company’s stock worth $1,410,000 after acquiring an additional 8,486 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Activity

In related news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $73.21 on Thursday. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $9.41 billion, a PE ratio of 23.24, a price-to-earnings-growth ratio of 1.79 and a beta of 0.87. The business’s 50-day moving average price is $74.29 and its 200-day moving average price is $72.43. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $85.39.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing the consensus estimate of $0.70 by ($0.04). The firm had revenue of $3.02 billion for the quarter, compared to the consensus estimate of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. Henry Schein’s revenue for the quarter was down 10.5% compared to the same quarter last year. During the same quarter last year, the company posted $1.21 earnings per share. Sell-side analysts forecast that Henry Schein, Inc. will post 5.07 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HSIC has been the topic of a number of recent research reports. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. JPMorgan Chase & Co. upped their price target on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research report on Wednesday, March 6th. SVB Leerink initiated coverage on Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 price target on the stock. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. Finally, Jefferies Financial Group boosted their price objective on Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $81.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.